Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. [electronic resource]
Producer: 20140616Description: 2171-6 p. digitalISSN:- 1530-6860
- Adrenergic beta-2 Receptor Agonists -- therapeutic use
- Albuterol -- therapeutic use
- Biopsy
- Electrocardiography
- Enzyme Replacement Therapy -- methods
- Female
- Glycogen Storage Disease Type II -- drug therapy
- Hand Strength
- Humans
- Male
- Muscle, Skeletal -- metabolism
- Pilot Projects
- Quadriceps Muscle -- metabolism
- Receptor, IGF Type 2 -- metabolism
- Time Factors
- Treatment Outcome
- Walking
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.